<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01270620</url>
  </required_header>
  <id_info>
    <org_study_id>SU-12062010-7277</org_study_id>
    <secondary_id>IRB: 4593</secondary_id>
    <secondary_id>SPO: 48391</secondary_id>
    <nct_id>NCT01270620</nct_id>
  </id_info>
  <brief_title>Desflurane or Propofol Anesthesia in Elderly Obese Patients Undergoing Total Knee Replacement</brief_title>
  <official_title>Desflurane or Propofol Anesthesia in Elderly Obese Patients Undergoing Total Knee Replacement: A Pilot Assessment of Short-term and Long-term Differences in Outcome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pedro Paulo Tanaka</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Baxter Healthcare Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      You are invited to participate in a research study assessing your mental status in the first
      days after your surgery and how you will be doing in the 2 years following the surgery. The
      investigators hope to learn more about the incidence of postoperative confusion and a
      possible relation with 2 anesthesia techniques that are routinely used. The first one is an
      anesthesia technique that uses the inhaled anesthetic gas desflurane and the second one is an
      anesthesia technique that uses the anesthetic propofol administered by infusion in a vein.
      The investigators are also looking to see if there is a relationship between anesthesia
      technique and cardiovascular outcomes. You were selected as a possible participant in this
      study because at your age this phenomenon appears to have a greater incidence.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Trial Objectives:

      This will be a randomized, prospective, single-center, assessor blinded pilot study comparing
      two different anesthesia techniques in 100 elderly obese patients undergoing primary total
      knee arthroplasty.

      Endpoints:

        -  The incidence of postoperative delirium as measured by the Confusion Assessment Score.
           Confusion assessment score will be administered at baseline, one hour after arrival in
           the post anesthesia care unit and 6-8, 24 and 48 hrs postoperatively.

        -  Cognitive function as measured by Test for Attentional Performance,
           Digit-Symbol-Substitution Test, Recal of Digit Span , Well-being Test BF-S, Spielberger
           State-Trait Anxiety Inventory and the Trail Making Test A and B. Cognitive function
           tests will be administered at baseline, 6-8 and 48 hrs post operatively. Postoperative
           Cognitive Dysfunction is defined as a 20% decline of the baseline values.

      Intraoperative

        -  Sensory block (femoral)

        -  Blood pressure

        -  Heart rate

        -  Patient state index values

        -  Degree of neuromuscular blockade

        -  Esophageal temperature

        -  End tidal concentration of CO2

        -  End tidal concentration of desflurane

        -  Amount of vasopressors (ephedrine or phenylephrine)

        -  Amount of intravascular fluid administration

        -  Dose and mean infusion rates of all IV drugs (propofol)

        -  Duration of anesthesia

        -  Duration of surgery

        -  Time to spontaneous breathing after desflurane/propofol discontinuation

        -  Time to eye opening after desflurane/propofol discontinuation

        -  Time to tracheal extubation after desflurane/propofol discontinuation

        -  Time to following command after desflurane/propofol discontinuation

      Post operative

        -  Nausea and vomiting: one hour after arrival in the post anesthesia care unit and 6-8, 24
           and 48 hrs postoperatively

        -  Pain visual analogue score measured one hour after arrival in the post anesthesia care
           unit and 6-8, 24 and 48 hrs postoperatively

        -  Recovery room time

        -  Amount of local anesthetics (ropivacaine)

        -  Amount of opioids (Patient controlled analgesia hydromorphone)

      Cardiovascular

        -  B-type natriuretic peptide measured preoperatively and on postoperative days 1 and 2

        -  N-terminal proB-type natriuretic peptide measured preoperatively and on postoperative
           days 1 and 2

        -  Troponin I measured preoperatively and on postoperative days 1 and 2

        -  Patients will be followed by a blinded investigator for a 2 year period to record the
           development of cardiac complications defined by a broad composite that included cardiac
           death and nonfatal myocardial infarction. Cardiac composite including: all-cause
           mortality, acute myocardial infarction, unstable angina, congestive heart failure, new
           atrial or ventricular dysrhythmia requiring treatment, and cerebrovascular insult.

      Protocol This will be a randomized, prospective, single-center, assessor blinded study
      comparing two different anesthesia techniques in 100 elderly obese patients undergoing
      primary total knee arthroplasty. We expect to enroll all patients in a 2 year period.

      The study will be performed according to the Declaration of Helsinki principles, and written
      informed consent will be obtained from each patient. Preoperatively baseline values will be
      obtained for the cardiovascular, mental status, respiratory and pain outcome measures.

      Mental status: During their preoperative visit patients will be given the neuropsychological
      tests in the following order: 1. Confusion Assessment Method . The confusion assessment
      method is a screening instrument for delirium consisting of four clinical criteria: (1) acute
      onset and fluctuating course, (2) inattention, (3) disorganized thinking, and (4) altered
      level of consciousness. For a person to be considered delirious, both the first and the
      second criteria and either the third or the fourth criteria have to be present. The confusion
      assessment method has a high inter-observer reliability (0.8 -1.0), a sensitivity of 94-100%,
      and a specificity of 90-95%. 2. Modified Mini-Mental State Examination. This extended measure
      of general cognition was developed to overcome shortcomings of the traditional Mini-Mental
      State Examination score, specifically its ceiling effects and narrow range of possible
      scores. The Modified Mini-Mental State Examination will be administered at the preoperative
      visit to assess the baseline cognitive function of the patient. 3. Computerized Test for
      Attentional Performance , Digit-Symbol-Substitution Test, Recall of Digit Span, Well-being
      Test BF-S, Spielberger State-Trait Anxiety Inventory and the Trail Making Test A and B.

      Patients will be visited for the first 2 days after surgery or until discharge, whichever
      came first, and the confusion assessment method will be administered one hour after arrival
      in the post anesthesia care unit and 6-8, 24 and 48 hrs postoperatively to determine whether
      the patient is experiencing delirium. Each patient will be interviewed by the same trained
      research assistant before surgery and during the postoperative visits. We will define the
      occurrence of delirium as the patient meeting the confusion assessment method criteria for
      delirium on any of the postoperative assessments. If a patient is positive for delirium, a
      second member of the research team will be consulted to verify the diagnosis. Cognitive
      function tests will be administered, 6-8 and 48 hrs post operatively. Postoperative Cognitive
      Dysfunction is defined as a 20% decline of the baseline values.

      Cardiovascular: Preoperative testing will include 12-lead ECG. Blood samples for Natriuretic
      peptide levels and N-terminal proB-type natriuretic peptide and Troponin I will be obtained
      at the time of the admission and on postoperative day 1 and day 2. Plasma NT-proB-type
      natriuretic peptide will be determined using the Elecsys proB-type natriuretic peptide
      sandwich immunoassay on an Elecsys 2010 (Roche Diagnostics, Basel, Switzerland). Two cut offs
      for NT-proB-type natriuretic peptide will be selected before the analyses, 300 pg/ml and 600
      pg/ml, with a value of less than 300 pg/ml shown to be optimal for ruling out heart failure
      as a predictor. B-type natriuretic peptide will be determined using immunoradiometric assay
      kit. Values of B-type natriuretic peptide (pg/mL) 31.0 Â± 2.4 are considered normal for
      patients over 65 years old.

      After discharge from the hospital patients will be followed blindly for a 2 year period to
      record the development of cardiac complications defined by a broad composite that included
      cardiac death and nonfatal myocardial infarction. Cardiac composite including: all-cause
      mortality, acute myocardial infarction, unstable angina, congestive heart failure, new atrial
      or ventricular dysrhythmia requiring treatment, and cerebrovascular insult. Information will
      be collected at 1, 3, 6, 12, 18 and 24 months after surgery.

      Outcome measures and postoperative complications including nausea and vomiting will be
      recorded by an assessor blinded to the treatment allocation.

      Patients will be randomly allocated to one of two treatment groups on the day of surgery
      using a computer generated assignment. Group D will receive desflurane and group P will
      receive propofol.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2010</start_date>
  <completion_date type="Actual">July 2015</completion_date>
  <primary_completion_date type="Actual">July 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Assessment of Delirium</measure>
    <time_frame>48 hours</time_frame>
    <description>The primary end point was the incidence of postoperative delirium as measured by the Confusion Assessment Method (CAM).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Recall of Digit Span</measure>
    <time_frame>Change &gt; 20% from baseline to 6-8 hours after surgery</time_frame>
    <description>â¢ The Digit Span subtest of the Wechsler Adult Intelligence Scale-Revised is a test that requires subjects to repeat a series of digits that have been verbally presented to them both forward and, in a later independent test, reverse order. It measures attention and working memory</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Recall of Digit Span</measure>
    <time_frame>Change &gt; 20% from baseline to 48 hours after surgery</time_frame>
    <description>â¢ The Digit Span subtest of the Wechsler Adult Intelligence Scale-Revised is a test that requires subjects to repeat a series of digits that have been verbally presented to them both forward and, in a later independent test, reverse order. It measures attention and working memory</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Digit Symbol Substitution Test</measure>
    <time_frame>Change &gt; 20% from baseline to 6-8 hours after surgery</time_frame>
    <description>â¢ The Digit Symbol Substitution Test (DSST) measures attention, working memory, sustained visual attention and psychomotor speed. Subjects are given a table that pairs digits and symbols, and asked to decipher a code using the table, completing as many as possible in 90 seconds. The DSST has been found to be more sensitive than other tests to changes in high-levels of cognition</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Digit Symbol Substitution Test</measure>
    <time_frame>Change &gt; 20% from baseline to 48 hours after surgery</time_frame>
    <description>â¢ The Digit Symbol Substitution Test (DSST) measures attention, working memory, sustained visual attention and psychomotor speed. Subjects are given a table that pairs digits and symbols, and asked to decipher a code using the table, completing as many as possible in 90 seconds. The DSST has been found to be more sensitive than other tests to changes in high-levels of cognition</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Trail Making Part A</measure>
    <time_frame>Change &gt; 20% from baseline to 6-8 hours after surgery</time_frame>
    <description>â¢ Trail Making Test is an executive measure of sequencing and cognitive flexibility. Trail A requires the subject to rapidly sequence a straightforward series. The scoring for this test is the time in seconds required for completion of the test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Trail Making Part A</measure>
    <time_frame>Change &gt; 20% from baseline to 48 hours after surgery</time_frame>
    <description>â¢ Trail Making Test is an executive measure of sequencing and cognitive flexibility. Trail A requires the subject to rapidly sequence a straightforward series. The scoring for this test is the time in seconds required for completion of the test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Trail Making Part B</measure>
    <time_frame>Change &gt; 20% from baseline to 6-8 hours after surgery</time_frame>
    <description>â¢ Trail Making Test is an executive measure of sequencing and cognitive flexibility. Trail B is a more difficult cognitive flexibility task requiring the subject to follow a sequential pattern while shifting cognitive sets and reflects executive functioning, although other cognitive abilities, such as psychomotor speed and visual scanning, are necessary for successful completion of the task. The scoring for this test is the time in seconds required for completion of the test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Trail Making Part B</measure>
    <time_frame>Change &gt; 20% from baseline to 48 hours after surgery</time_frame>
    <description>Trail Making Test is an executive measure of sequencing and cognitive flexibility. Trail B is a more difficult cognitive flexibility task requiring the subject to follow a sequential pattern while shifting cognitive sets and reflects executive functioning, although other cognitive abilities, such as psychomotor speed and visual scanning, are necessary for successful completion of the task. The scoring for this test is the time in seconds required for completion of the test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>- Time to Spontaneous Breathing After Desflurane/Propofol Discontinuation</measure>
    <time_frame>first day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>- Time to Eye Opening After Desflurane/Propofol Discontinuation</measure>
    <time_frame>first day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>- Time to Tracheal Extubation After Desflurane/Propofol Discontinuation</measure>
    <time_frame>first day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>- Time to Following Command After Desflurane/Propofol Discontinuation</measure>
    <time_frame>first day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nausea and Vomiting</measure>
    <time_frame>48 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recovery Room Time</measure>
    <time_frame>first day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>B-type Natriuretic Peptide</measure>
    <time_frame>Change from Baseline to day one</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>N-terminal proBNP</measure>
    <time_frame>Change from baseline to day one</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Troponin I</measure>
    <time_frame>2 days</time_frame>
    <description>Patients who had troponin level &gt; 0.2 ng/mL</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>BNP</measure>
    <time_frame>Change form baseline to post-operative day 2</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ProBNP</measure>
    <time_frame>Change from baseline to post-operative day 2</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of Surgery</measure>
    <time_frame>Time from Incision to closure of surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of Anesthesia</measure>
    <time_frame>Time from induction to extubation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Amount of Intraoperative Fentanyl</measure>
    <time_frame>From the anesthesia induction until extubation</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Obesity</condition>
  <condition>Arthritis</condition>
  <arm_group>
    <arm_group_label>Propofol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive propofol as general anesthetics.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Desflurane</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive desflurane as general anesthetics.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>propofol</intervention_name>
    <description>comparison of the incidence in delirium and post-operative cognitive dysfunction from propofol and desflurane in patients under general anesthesia</description>
    <arm_group_label>Propofol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Desflurane</intervention_name>
    <description>comparison of the incidence in delirium and post-operative cognitive dysfunction from propofol and desflurane in patients under general anesthesia</description>
    <arm_group_label>Desflurane</arm_group_label>
    <other_name>Suprane</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 65 years old

          -  Body mass index &gt; 30 kg/m2

          -  Undergoing primary total knee arthroplasty surgery

          -  American society of anesthesiology classification II-III

        Exclusion Criteria:

          -  Patient refusal to participate in the study

          -  Patient refusal or failure of regional block

          -  Patients with preexisting neuro-cognitive disorders

          -  Known intolerance to any of the drugs to be used according to the study protocol
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hendrikus Lemmens</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pedro Paulo Tanaka</last_name>
    <role>Study Director</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Stanford University School of Medicine</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 14, 2010</study_first_submitted>
  <study_first_submitted_qc>January 4, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 5, 2011</study_first_posted>
  <results_first_submitted>July 18, 2015</results_first_submitted>
  <results_first_submitted_qc>August 13, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">September 16, 2015</results_first_posted>
  <last_update_submitted>October 1, 2015</last_update_submitted>
  <last_update_submitted_qc>October 1, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 22, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Stanford University</investigator_affiliation>
    <investigator_full_name>Pedro Paulo Tanaka</investigator_full_name>
    <investigator_title>Clinical Associate Professor</investigator_title>
  </responsible_party>
  <keyword>elderly obese</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Desflurane</mesh_term>
    <mesh_term>Isoflurane</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>One hundred patients provided consented to participate in the study during June 2010 to August 2014.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Desflurane Group</title>
          <description>Patients will receive desflurane as general anesthetic. Desflurane is inhaled agent which will be provided continuously via ETT in concentrations varying from 4-6% according to BIS monitoring.
Desflurane: comparison of the incidence in delirium and post-operative cognitive dysfunction from propofol and desflurane in patients under general anesthesia</description>
        </group>
        <group group_id="P2">
          <title>Propofol Group</title>
          <description>Patients will receive propofol as general anesthetic Propofol is an intravenous agent which will be provided continuously via IV in doses varying from 100 to 200 mcg/kg/min according to BIS monitoring.
Propofol: comparison of the incidence in delirium and post-operative cognitive dysfunction from propofol and desflurane in patients under general anesthesia</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="50"/>
                <participants group_id="P2" count="50"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="49"/>
                <participants group_id="P2" count="47"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Desflurane</title>
          <description>Patients received propofol or desflurane as general anesthetic for total knee replacement.
Inclusion criteria: Age &gt; 65 years old; BMI &gt; 30 kg/m2; undergoing primary total knee replacement surgery; and ASA classification II-III</description>
        </group>
        <group group_id="B2">
          <title>Propofol</title>
          <description>Patients received propofol or desflurane as general anesthetic for total knee replacement.
Inclusion criteria: Age &gt; 65 years old; BMI &gt; 30 kg/m2; undergoing primary total knee replacement surgery; and ASA classification II-III</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="50"/>
            <count group_id="B2" value="50"/>
            <count group_id="B3" value="100"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="50"/>
                    <measurement group_id="B2" value="50"/>
                    <measurement group_id="B3" value="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="70" spread="4.0"/>
                    <measurement group_id="B2" value="71" spread="5.8"/>
                    <measurement group_id="B3" value="70.5" spread="4.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="34"/>
                    <measurement group_id="B3" value="55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="29"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="50"/>
                    <measurement group_id="B2" value="50"/>
                    <measurement group_id="B3" value="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Assessment of Delirium</title>
        <description>The primary end point was the incidence of postoperative delirium as measured by the Confusion Assessment Method (CAM).</description>
        <time_frame>48 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Desflurane</title>
            <description>Patients received desflurane as general anesthetic
propofol or desflurane: comparison of the incidence in delirium and post-operative cognitive dysfunction from propofol and desflurane in patients under general anesthesia</description>
          </group>
          <group group_id="O2">
            <title>Propofol</title>
            <description>Patients received propofol as general anesthetic
propofol or desflurane: comparison of the incidence in delirium and post-operative cognitive dysfunction from propofol and desflurane in patients under general anesthesia</description>
          </group>
        </group_list>
        <measure>
          <title>Assessment of Delirium</title>
          <description>The primary end point was the incidence of postoperative delirium as measured by the Confusion Assessment Method (CAM).</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
                <count group_id="O2" value="47"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>- Time to Spontaneous Breathing After Desflurane/Propofol Discontinuation</title>
        <time_frame>first day</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Desflurane</title>
            <description>Patients received desflurane as general anesthetic</description>
          </group>
          <group group_id="O2">
            <title>Propofol</title>
            <description>Patients received propofol as general anesthetic</description>
          </group>
        </group_list>
        <measure>
          <title>- Time to Spontaneous Breathing After Desflurane/Propofol Discontinuation</title>
          <units>seconds</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
                <count group_id="O2" value="47"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="270" lower_limit="120" upper_limit="480"/>
                    <measurement group_id="O2" value="300" lower_limit="120" upper_limit="465"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>- Time to Eye Opening After Desflurane/Propofol Discontinuation</title>
        <time_frame>first day</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Desflurane</title>
            <description>Patients received desflurane as general anesthetic</description>
          </group>
          <group group_id="O2">
            <title>Propofol</title>
            <description>Patients received propofol as general anesthetic</description>
          </group>
        </group_list>
        <measure>
          <title>- Time to Eye Opening After Desflurane/Propofol Discontinuation</title>
          <units>seconds</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
                <count group_id="O2" value="47"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="420" lower_limit="240" upper_limit="600"/>
                    <measurement group_id="O2" value="395" lower_limit="180" upper_limit="655"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>- Time to Tracheal Extubation After Desflurane/Propofol Discontinuation</title>
        <time_frame>first day</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Desflurane</title>
            <description>Patient received desflurane as a general anesthesia</description>
          </group>
          <group group_id="O2">
            <title>Propofol</title>
            <description>Patient received propofol as a general anesthesia</description>
          </group>
        </group_list>
        <measure>
          <title>- Time to Tracheal Extubation After Desflurane/Propofol Discontinuation</title>
          <units>seconds</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
                <count group_id="O2" value="47"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="420" lower_limit="300" upper_limit="600"/>
                    <measurement group_id="O2" value="526" lower_limit="300" upper_limit="720"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>- Time to Following Command After Desflurane/Propofol Discontinuation</title>
        <time_frame>first day</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Desflurane</title>
            <description>Patient received desflurane as a general anesthesia</description>
          </group>
          <group group_id="O2">
            <title>Propofol</title>
            <description>Patient received propofol as a general anesthesia</description>
          </group>
        </group_list>
        <measure>
          <title>- Time to Following Command After Desflurane/Propofol Discontinuation</title>
          <units>seconds</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
                <count group_id="O2" value="47"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="480" lower_limit="300" upper_limit="600"/>
                    <measurement group_id="O2" value="450" lower_limit="240" upper_limit="660"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Nausea and Vomiting</title>
        <time_frame>48 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Desflurane</title>
            <description>Patient received desflurane as a general anesthesia</description>
          </group>
          <group group_id="O2">
            <title>Propofol</title>
            <description>Patient received propofol as a general anesthesia</description>
          </group>
        </group_list>
        <measure>
          <title>Nausea and Vomiting</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
                <count group_id="O2" value="47"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Recovery Room Time</title>
        <time_frame>first day</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Desflurane</title>
            <description>Patient received desflurane as a general anesthesia</description>
          </group>
          <group group_id="O2">
            <title>Propofol</title>
            <description>Patient received propofol as a general anesthesia</description>
          </group>
        </group_list>
        <measure>
          <title>Recovery Room Time</title>
          <units>minutes</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
                <count group_id="O2" value="47"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="65" lower_limit="46" upper_limit="76"/>
                    <measurement group_id="O2" value="60.5" lower_limit="45" upper_limit="83.75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>B-type Natriuretic Peptide</title>
        <time_frame>Change from Baseline to day one</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Desflurane</title>
            <description>Patient received desflurane as a general anesthesia</description>
          </group>
          <group group_id="O2">
            <title>Propofol</title>
            <description>Patient received propofol as a general anesthesia</description>
          </group>
        </group_list>
        <measure>
          <title>B-type Natriuretic Peptide</title>
          <units>ng/L</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
                <count group_id="O2" value="47"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="47" lower_limit="31" upper_limit="76"/>
                    <measurement group_id="O2" value="43" lower_limit="14.5" upper_limit="77.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>N-terminal proBNP</title>
        <time_frame>Change from baseline to day one</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Desflurane</title>
            <description>Patient received desflurane as a general anesthesia</description>
          </group>
          <group group_id="O2">
            <title>Propofol</title>
            <description>Patient received propofol as a general anesthesia</description>
          </group>
        </group_list>
        <measure>
          <title>N-terminal proBNP</title>
          <units>ng/L</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
                <count group_id="O2" value="47"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="83" lower_limit="46" upper_limit="159"/>
                    <measurement group_id="O2" value="86" lower_limit="9" upper_limit="194"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Troponin I</title>
        <description>Patients who had troponin level &gt; 0.2 ng/mL</description>
        <time_frame>2 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Desflurane</title>
            <description>Patient received desflurane as a general anesthesia</description>
          </group>
          <group group_id="O2">
            <title>Propofol</title>
            <description>Patient received propofol as a general anesthesia</description>
          </group>
        </group_list>
        <measure>
          <title>Troponin I</title>
          <description>Patients who had troponin level &gt; 0.2 ng/mL</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
                <count group_id="O2" value="47"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>BNP</title>
        <time_frame>Change form baseline to post-operative day 2</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Desflurane</title>
            <description>Patient received desflurane as a general anesthesia</description>
          </group>
          <group group_id="O2">
            <title>Propofol</title>
            <description>Patient received propofol as a general anesthesia</description>
          </group>
        </group_list>
        <measure>
          <title>BNP</title>
          <units>ng/L</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
                <count group_id="O2" value="47"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="83.5" lower_limit="35.5" upper_limit="174"/>
                    <measurement group_id="O2" value="92" lower_limit="45.5" upper_limit="196.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>ProBNP</title>
        <time_frame>Change from baseline to post-operative day 2</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Desflurane</title>
            <description>Patient received desflurane as a general anesthesia</description>
          </group>
          <group group_id="O2">
            <title>Propofol</title>
            <description>Patient received propofol as a general anesthesia</description>
          </group>
        </group_list>
        <measure>
          <title>ProBNP</title>
          <units>ng/L</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
                <count group_id="O2" value="47"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="330" lower_limit="147" upper_limit="682.5"/>
                    <measurement group_id="O2" value="311.5" lower_limit="153.8" upper_limit="573.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Recall of Digit Span</title>
        <description>â¢ The Digit Span subtest of the Wechsler Adult Intelligence Scale-Revised is a test that requires subjects to repeat a series of digits that have been verbally presented to them both forward and, in a later independent test, reverse order. It measures attention and working memory</description>
        <time_frame>Change &gt; 20% from baseline to 6-8 hours after surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Desflurane</title>
            <description>Patients received desflurane as a general anesthetic</description>
          </group>
          <group group_id="O2">
            <title>Propofol</title>
            <description>Patients received propofol as a general anesthetic</description>
          </group>
        </group_list>
        <measure>
          <title>Recall of Digit Span</title>
          <description>â¢ The Digit Span subtest of the Wechsler Adult Intelligence Scale-Revised is a test that requires subjects to repeat a series of digits that have been verbally presented to them both forward and, in a later independent test, reverse order. It measures attention and working memory</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
                <count group_id="O2" value="47"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Recall of Digit Span</title>
        <description>â¢ The Digit Span subtest of the Wechsler Adult Intelligence Scale-Revised is a test that requires subjects to repeat a series of digits that have been verbally presented to them both forward and, in a later independent test, reverse order. It measures attention and working memory</description>
        <time_frame>Change &gt; 20% from baseline to 48 hours after surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Desflurane</title>
            <description>Patients received desflurane as a general anesthetic</description>
          </group>
          <group group_id="O2">
            <title>Propofol</title>
            <description>Patients received propofol as a general anesthetic</description>
          </group>
        </group_list>
        <measure>
          <title>Recall of Digit Span</title>
          <description>â¢ The Digit Span subtest of the Wechsler Adult Intelligence Scale-Revised is a test that requires subjects to repeat a series of digits that have been verbally presented to them both forward and, in a later independent test, reverse order. It measures attention and working memory</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
                <count group_id="O2" value="47"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Digit Symbol Substitution Test</title>
        <description>â¢ The Digit Symbol Substitution Test (DSST) measures attention, working memory, sustained visual attention and psychomotor speed. Subjects are given a table that pairs digits and symbols, and asked to decipher a code using the table, completing as many as possible in 90 seconds. The DSST has been found to be more sensitive than other tests to changes in high-levels of cognition</description>
        <time_frame>Change &gt; 20% from baseline to 6-8 hours after surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Desflurane</title>
            <description>Patients received desflurane as a general anesthetic</description>
          </group>
          <group group_id="O2">
            <title>Propofol</title>
            <description>Patients received propofol as a general anesthetic</description>
          </group>
        </group_list>
        <measure>
          <title>Digit Symbol Substitution Test</title>
          <description>â¢ The Digit Symbol Substitution Test (DSST) measures attention, working memory, sustained visual attention and psychomotor speed. Subjects are given a table that pairs digits and symbols, and asked to decipher a code using the table, completing as many as possible in 90 seconds. The DSST has been found to be more sensitive than other tests to changes in high-levels of cognition</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
                <count group_id="O2" value="47"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22"/>
                    <measurement group_id="O2" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Digit Symbol Substitution Test</title>
        <description>â¢ The Digit Symbol Substitution Test (DSST) measures attention, working memory, sustained visual attention and psychomotor speed. Subjects are given a table that pairs digits and symbols, and asked to decipher a code using the table, completing as many as possible in 90 seconds. The DSST has been found to be more sensitive than other tests to changes in high-levels of cognition</description>
        <time_frame>Change &gt; 20% from baseline to 48 hours after surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Desflurane</title>
            <description>Patients received desflurane as a general anesthetic</description>
          </group>
          <group group_id="O2">
            <title>Propofol</title>
            <description>Patients received propofol as a general anesthetic</description>
          </group>
        </group_list>
        <measure>
          <title>Digit Symbol Substitution Test</title>
          <description>â¢ The Digit Symbol Substitution Test (DSST) measures attention, working memory, sustained visual attention and psychomotor speed. Subjects are given a table that pairs digits and symbols, and asked to decipher a code using the table, completing as many as possible in 90 seconds. The DSST has been found to be more sensitive than other tests to changes in high-levels of cognition</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
                <count group_id="O2" value="47"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24"/>
                    <measurement group_id="O2" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Trail Making Part A</title>
        <description>â¢ Trail Making Test is an executive measure of sequencing and cognitive flexibility. Trail A requires the subject to rapidly sequence a straightforward series. The scoring for this test is the time in seconds required for completion of the test</description>
        <time_frame>Change &gt; 20% from baseline to 6-8 hours after surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Desflurane</title>
            <description>Patients received desflurane as a general anesthetic</description>
          </group>
          <group group_id="O2">
            <title>Propofol</title>
            <description>Patients received propofol as a general anesthetic</description>
          </group>
        </group_list>
        <measure>
          <title>Trail Making Part A</title>
          <description>â¢ Trail Making Test is an executive measure of sequencing and cognitive flexibility. Trail A requires the subject to rapidly sequence a straightforward series. The scoring for this test is the time in seconds required for completion of the test</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
                <count group_id="O2" value="47"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25"/>
                    <measurement group_id="O2" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Trail Making Part A</title>
        <description>â¢ Trail Making Test is an executive measure of sequencing and cognitive flexibility. Trail A requires the subject to rapidly sequence a straightforward series. The scoring for this test is the time in seconds required for completion of the test</description>
        <time_frame>Change &gt; 20% from baseline to 48 hours after surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Desflurane</title>
            <description>Patients received desflurane as a general anesthetic</description>
          </group>
          <group group_id="O2">
            <title>Propofol</title>
            <description>Patients received propofol as a general anesthetic</description>
          </group>
        </group_list>
        <measure>
          <title>Trail Making Part A</title>
          <description>â¢ Trail Making Test is an executive measure of sequencing and cognitive flexibility. Trail A requires the subject to rapidly sequence a straightforward series. The scoring for this test is the time in seconds required for completion of the test</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
                <count group_id="O2" value="47"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26"/>
                    <measurement group_id="O2" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Trail Making Part B</title>
        <description>â¢ Trail Making Test is an executive measure of sequencing and cognitive flexibility. Trail B is a more difficult cognitive flexibility task requiring the subject to follow a sequential pattern while shifting cognitive sets and reflects executive functioning, although other cognitive abilities, such as psychomotor speed and visual scanning, are necessary for successful completion of the task. The scoring for this test is the time in seconds required for completion of the test</description>
        <time_frame>Change &gt; 20% from baseline to 6-8 hours after surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Desflurane</title>
            <description>Patients received desflurane as a general anesthetic</description>
          </group>
          <group group_id="O2">
            <title>Propofol</title>
            <description>Patients received propofol as a general anesthetic</description>
          </group>
        </group_list>
        <measure>
          <title>Trail Making Part B</title>
          <description>â¢ Trail Making Test is an executive measure of sequencing and cognitive flexibility. Trail B is a more difficult cognitive flexibility task requiring the subject to follow a sequential pattern while shifting cognitive sets and reflects executive functioning, although other cognitive abilities, such as psychomotor speed and visual scanning, are necessary for successful completion of the task. The scoring for this test is the time in seconds required for completion of the test</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
                <count group_id="O2" value="47"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29"/>
                    <measurement group_id="O2" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Trail Making Part B</title>
        <description>Trail Making Test is an executive measure of sequencing and cognitive flexibility. Trail B is a more difficult cognitive flexibility task requiring the subject to follow a sequential pattern while shifting cognitive sets and reflects executive functioning, although other cognitive abilities, such as psychomotor speed and visual scanning, are necessary for successful completion of the task. The scoring for this test is the time in seconds required for completion of the test</description>
        <time_frame>Change &gt; 20% from baseline to 48 hours after surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Desflurane</title>
            <description>Patients received desflurane as a general anesthetic</description>
          </group>
          <group group_id="O2">
            <title>Propofol</title>
            <description>Patients received propofol as a general anesthetic</description>
          </group>
        </group_list>
        <measure>
          <title>Trail Making Part B</title>
          <description>Trail Making Test is an executive measure of sequencing and cognitive flexibility. Trail B is a more difficult cognitive flexibility task requiring the subject to follow a sequential pattern while shifting cognitive sets and reflects executive functioning, although other cognitive abilities, such as psychomotor speed and visual scanning, are necessary for successful completion of the task. The scoring for this test is the time in seconds required for completion of the test</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
                <count group_id="O2" value="47"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29"/>
                    <measurement group_id="O2" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Duration of Surgery</title>
        <time_frame>Time from Incision to closure of surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Desflurane</title>
            <description>Patients received desflurane as a general anesthetic</description>
          </group>
          <group group_id="O2">
            <title>Propofol</title>
            <description>Patients received propofol as a general anesthetic</description>
          </group>
        </group_list>
        <measure>
          <title>Duration of Surgery</title>
          <units>minutes</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
                <count group_id="O2" value="47"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="103.5" lower_limit="91.5" upper_limit="117"/>
                    <measurement group_id="O2" value="95" lower_limit="84.25" upper_limit="123"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Duration of Anesthesia</title>
        <time_frame>Time from induction to extubation</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Desflurane</title>
            <description>Patients received desflurane as a general anesthetic</description>
          </group>
          <group group_id="O2">
            <title>Propofol</title>
            <description>Patients received propofol as a general anesthetic</description>
          </group>
        </group_list>
        <measure>
          <title>Duration of Anesthesia</title>
          <units>minutes</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
                <count group_id="O2" value="47"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="137.5" lower_limit="121.2" upper_limit="156.5"/>
                    <measurement group_id="O2" value="133.5" lower_limit="115" upper_limit="159.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Amount of Intraoperative Fentanyl</title>
        <time_frame>From the anesthesia induction until extubation</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Desflurane</title>
            <description>Patients received desflurane as a general anesthetic</description>
          </group>
          <group group_id="O2">
            <title>Propofol</title>
            <description>Patients received propofol as a general anesthetic</description>
          </group>
        </group_list>
        <measure>
          <title>Amount of Intraoperative Fentanyl</title>
          <units>micrograms</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
                <count group_id="O2" value="47"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="350" lower_limit="250" upper_limit="418.8"/>
                    <measurement group_id="O2" value="350" lower_limit="300" upper_limit="450"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>During the hospital length of stay up to one week.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Desflurane</title>
          <description>Patients will receive desflurane as general anesthetic
propofol or desflurane: comparison of the incidence in delirium and post-operative cognitive dysfunction from propofol and desflurane in patients under general anesthesia</description>
        </group>
        <group group_id="E2">
          <title>Propofol</title>
          <description>Patients will receive propofol as general anesthetic
propofol or desflurane: comparison of the incidence in delirium and post-operative cognitive dysfunction from propofol and desflurane in patients under general anesthesia</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Pedro Tanaka</name_or_title>
      <organization>Stanford University School of Medicine</organization>
      <phone>6507244066</phone>
      <email>ptanaka@stanford.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

